Pfizer near deal to buy cancer drug firm Medivation for almost $14 billion

Pfizer is in advanced talks to acquire Medivation for close to $14 billion, as it seeks to boost its oncology portfolio.

from Mergers and Acquisitions http://ift.tt/2bF5nj9